---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-182591"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T18:21:56.782695+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HCA Q2 2024 rev $17.49B, EPS $5.53, raises FY guidance

## Summary
- Revenue $17.492B (+10.3% YoY); net income $1.461B ($5.53 diluted EPS) vs $1.193B ($4.29).
- Adjusted EBITDA $3.550B (+16.2% YoY); same facility admissions +5.8%, ER visits +5.5%.
- FY2024 guidance raised: rev $69.75-71.75B (prev $67.75-70.25B), EPS $21.60-22.80 (prev $19.70-21.20).
- Board declared quarterly dividend $0.66/share, payable Sept 30, record Sept 16.
- Repurchased 4.217M shares at $1.367B in Q2; $4.228B remaining under buyback authorization.

## SEC filing metadata
- accession: 0001193125-24-182591
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312524182591/0001193125-24-182591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312524182591/d873924d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-182591
- JSON: https://secwatch.observer/filing/0001193125-24-182591.json
- Plain text: https://secwatch.observer/filing/0001193125-24-182591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.